A monoclonal antibody to human ventricular myosin light chains

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 5/18 (2006.01) C07K 16/18 (2006.01) G01N 33/577 (2006.01)

Patent

CA 2201152

A monoclonal antibody having high affinity to the cardiac isoform of human myosin light chains is described. The monoclonal antibody is prepared against a synthetic peptide from the amino terminal end of myosin light chain-1. The monoclonal antibody can be used as a reagent in an immunoassay system to identify blood, serum or plasma levels of myosin light chains. Such an immunoassay system can be used for diagnosing and quantifying myocardial necrosis and infarction.

L'invention concerne un anticorps monoclonal présentant une affinité élevée vis-à-vis de l'isoforme cardiaque de chaînes légères de myosine humaine. L'anticorps monoclonal est préparé contre un peptide synthétique tiré de l'extrémité amino-terminale de la chaîne légère 1 de la myosine. On peut utiliser l'anticorps monoclonal comme réactif dans un système d'immunodosage afin d'identifier des taux de chaînes légères de myosine dans le sang, le sérum ou le plasma. On peut utiliser un tel système d'immunodosage dans le diagnostic de l'infarctus du myocarde et la quantification de la nécrose myocardique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A monoclonal antibody to human ventricular myosin light chains does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A monoclonal antibody to human ventricular myosin light chains, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A monoclonal antibody to human ventricular myosin light chains will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1593711

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.